Related references
Note: Only part of the references are listed.Novel PF74-like small molecules targeting the HIV-1 capsid protein: Balance of potency and metabolic stability
Lei Wang et al.
ACTA PHARMACEUTICA SINICA B (2021)
Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities
Lin Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules
Sanjeev Kumar V. Vernekar et al.
VIRUSES-BASEL (2020)
Novel HIV-1 capsid-targeting small molecules of the PF74 binding site
Lei Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Chemical profiling of HIV-1 capsid-targeting antiviral PF74
Lei Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Clinical targeting of HIV capsid protein with a long-acting small molecule
John O. Link et al.
NATURE (2020)
HIV-1 Maturation: Lessons Learned from Inhibitors
Alex B. Kleinpeter et al.
VIRUSES-BASEL (2020)
Structural and mechanistic bases for a potent HIV-1 capsid inhibitor
Stephanie M. Bester et al.
SCIENCE (2020)
Tryptophan Metabolic Pathways and Brain Serotonergic Activity: A Comparative Review
Erik Hoglund et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Multiple Roles of HIV-1 Capsid during the Virus Replication Cycle
Mariia Novikova et al.
VIROLOGICA SINICA (2019)
Diphtheria Toxin A-Resistant Cell Lines Enable Robust Production and Evaluation of DTA-Encoding Lentiviruses
Margaret J. Lange et al.
SCIENTIFIC REPORTS (2019)
GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds
Kamal Singh et al.
FRONTIERS IN MICROBIOLOGY (2019)
A Conformational Restriction Strategy for the Identification of a Highly Selective Pyrimido-pyrrolo-oxazine mTOR Inhibitor
Chiara Borsari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Cyclophilin A protects HIV-1 from restriction by human TRIM5α
Kyusik Kim et al.
NATURE MICROBIOLOGY (2019)
HIV-1 nuclear import in macrophages is regulated by CPSF6-capsid interactions at the nuclear pore complex
David Alejandro Bejarano et al.
ELIFE (2019)
Importance of Rigidity in Designing Small Molecule Drugs To Tackle Protein-Protein Interactions (PPIs) through Stabilization of Desired Conformers
Alastair D. G. Lawson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Nup153 Unlocks the Nuclear Pore Complex for HIV-1 Nuclear Translocation in Nondividing Cells
Cindy Buffone et al.
JOURNAL OF VIROLOGY (2018)
Inhibitors of the HIV-1 capsid, a target of opportunity
Stephanie K. Carnes et al.
CURRENT OPINION IN HIV AND AIDS (2018)
Capsid-CPSF6 Interaction Licenses Nuclear HIV-1 Trafficking to Sites of Viral DNA Integration
Vasudevan Achuthan et al.
CELL HOST & MICROBE (2018)
Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library
Gaochan Wu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Urinary intermediates of tryptophan as indicators of the gut microbial metabolism
Tereza Pavlova et al.
ANALYTICA CHIMICA ACTA (2017)
A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin
Gregory A. Sowd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation
Annachiara Rosa et al.
NATURE (2015)
HIV-1 assembly, release and maturation
Eric O. Freed
NATURE REVIEWS MICROBIOLOGY (2015)
X-ray crystal structures of native HIV-1 capsid protein reveal conformational variability
Anna T. Gres et al.
SCIENCE (2015)
Direct Visualization of HIV-1 Replication Intermediates Shows that Capsid and CPSF6 Modulate HIV-1 Intra-nuclear Invasion and Integration
Christopher R. Chin et al.
CELL REPORTS (2015)
Host Cofactors and Pharmacologic Ligands Share an Essential Interface in HIV-1 Capsid That Is Lost upon Disassembly
Amanda J. Price et al.
PLOS PATHOGENS (2014)
Discovery of Novel Small-Molecule HIV-1 Replication Inhibitors That Stabilize Capsid Complexes
Louie Lamorte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Distinct Effects of Two HIV-1 Capsid Assembly Inhibitor Families That Bind the Same Site within the N-Terminal Domain of the Viral CA Protein
Christopher T. Lemke et al.
JOURNAL OF VIROLOGY (2012)
Atomic-level modelling of the HIV capsid
Owen Pornillos et al.
NATURE (2011)
HIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention
Wade S. Blair et al.
PLOS PATHOGENS (2010)
X-Ray Structures of the Hexameric Building Block of the HIV Capsid
Owen Pornillos et al.
CELL (2009)
Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1CA protein
Brian N. Kelly et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Ligand configurational entropy and protein binding
Chia-en A. Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Share Paper
